Figure 1.

Correlation between cfDNA levels and patients with different Miller‐Payne grades. A, The Alu 111‐bp fragment levels increased after the first NCT in patients with Miller‐Payne 3‐5 grades. The Alu 111‐bp fragment levels remained stable during NCT in the low‐R group compared with the high‐R group. The Alu 260‐bp fragment levels increased after the NCT in both groups. CFDI remained at a constant level. B, No significant difference in the levels of both Alus and CFDI was found between different groups during the whole NCT